A 42-year-old woman presents to the clinic for concern about a lump she noticed in her neck two weeks ago. She is asymptomatic, denying any history of hoarseness, dysphagia, or prior radiation exposure to the head or neck. She has not had any recent illness. Past medical history is negative, and she does not take any medications. Physical examination reveals a firm, 1.5-cm, non-tender nodule in the right lobe of the thyroid gland. No cervical lymphadenopathy is present. Laboratory studies show a serum thyroid-stimulating hormone (TSH) of 0.2 μU/mL (Normal: 0.5–5.0 μU/mL).
Which of the following is the most appropriate next step in management?
The correct answer is:
D) Thyroid scintigraphy (radioiodine uptake scan)
The diagnostic pathway for a thyroid nodule is branched based on the patient's thyroid function status. When a nodule is discovered, the first step is to measure the serum TSH level to determine if the nodule is potentially hyperfunctioning. In this patient, the TSH is suppressed (0.2 μU/mL), indicating a hyperthyroid or subclinical hyperthyroid state. In the setting of a low TSH, the most appropriate next step is thyroid scintigraphy (radioiodine uptake scan). This imaging modality allows the clinician to determine the functional status of the nodule. If the scan reveals a hyperfunctioning "hot" nodule, the risk of malignancy is exceedingly low (<1%), and a biopsy is generally not required. If the nodule is "cold" or "iso-functioning," it carries a higher risk of malignancy and requires further evaluation with ultrasound and potentially fine-needle aspiration.
Answer choice A: Calcitonin level measurement, is incorrect. This is typically reserved for cases where medullary thyroid carcinoma is suspected, such as in patients with a family history of multiple endocrine neoplasia (MEN) type 2. It is not a routine part of the initial nodule workup.
Answer choice B: Fine-needle aspiration (FNA) biopsy, is incorrect. While FNA is the gold standard for diagnosing thyroid cancer, it should not be the immediate next step when the TSH is low. Performing an FNA before scintigraphy may lead to unnecessary invasive procedures on hyperfunctioning nodules that are almost always benign.
Answer choice C: Serum thyroglobulin level measurement, is incorrect. Thyroglobulin is a useful marker for monitoring recurrence in patients who have already been treated for differentiated thyroid cancer. It has no diagnostic value in the initial evaluation of a nodule because it is often elevated in benign conditions like Graves' disease or thyroiditis.
Answer choice E: Thyroid ultrasound, is incorrect. If the TSH had been normal or elevated, a thyroid ultrasound would be the preferred next step. However, when TSH is low, a radioiodine uptake scan is prioritized to evaluate the functional status of the nodule first.
Key Learning Point
The diagnostic pathway for a thyroid nodule is branched based on the serum TSH level. A low TSH should be followed by thyroid scintigraphy to identify hyperfunctioning nodules, which rarely require biopsy. A normal or high TSH should be followed by a thyroid ultrasound to look for suspicious features that would mandate a fine-needle aspiration biopsy.
